Post-Ischemic Treatment of Recombinant Human Secretory Leukocyte Protease Inhibitor (rhSLPI) Reduced Myocardial Ischemia/Reperfusion Injury

Podsawee Mongkolpathumrat, Sarawut Kumphune|Biomedicines|2021

Cited by 14